IZILOX Side Effects

6749074-3 | Hepatic Enzyme Increased, Pyrexia, Rash
on May 25, 2010 Female patient from FRANCE , 74 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, pyrexia, rash (What is rash?). Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with MYAMBUTOL (Total Daily Dose: 1200 Mg Unit Dose: 400 Mg) (View Myambutol Review and Myambutol Label ), PIRILENE (Total Daily Dose: 1 G Unit Dose: 500 Mg) (View Pirilene Review and Pirilene Label ), RIFADIN (View Rifadin Review and Rifadin Label ), RIMIFON (View Rimifon Review and Rimifon Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6730961-7 | Contusion, Haemorrhage
Patient was taking Izilox (View Usage). Patient had the following side effects: contusion, haemorrhage on Apr 09, 2010 from FRANCE Additional patient health information: Female patient , 65 years of age, was diagnosed with sinusitis (What is sinusitis?) and. Izilox dosage: . During the same period patient was treated with DAFALGAN (View Dafalgan Review and Dafalgan Label ), IBUPROFENE (View Ibuprofene Review and Ibuprofene Label ), NASONEX (View Nasonex Review and Nasonex Label ). Patient was hospitalized.

6727615-X | Contusion, Haemorrhage
Adverse event was reported on Apr 09, 2010 by a Female patient taking Izilox (View Usage) (Dosage: ) was diagnosed with sinusitis (What is sinusitis?) and. Location: FRANCE , 65 years of age, After Izilox was administered, patient had the following side effects: contusion, haemorrhage. During the same period patient was treated with DAFALGAN (View Dafalgan Review and Dafalgan Label ), IBUPROFENE (View Ibuprofene Review and Ibuprofene Label ), NASONEX (View Nasonex Review and Nasonex Label ). Patient was hospitalized.

6688319-5 | Bradycardia, Palpitations, Ventricular Extrasystoles
on Apr 12, 2010 Female patient from FRANCE , 37 years of age, was diagnosed with infection prophylaxis, acute myeloid leukaemia and was treated with Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, palpitations, ventricular extrasystoles. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with ACUPAN (View Acupan Review and Acupan Label ), ZOPHREN (As Used: 8/4 Mg/ml) (View Zophren Review and Zophren Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), NOXAFIL (View Noxafil Review and Noxafil Label ), AMIKIN (View Amikin Review and Amikin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LUTENYL (View Lutenyl Review and Lutenyl Label ).


6657677-X | Erythema, Facial Bones Fracture, Fall, Loss Of Consciousness, Malaise
on Mar 18, 2010 Female patient from FRANCE , 66 years of age, was diagnosed with bronchitis (What is bronchitis?), hypertension, tachycardia and was treated with Izilox (View Usage). Patient had the following side effects: erythema, facial bones fracture, fall (What is fall?), loss of consciousness, malaise. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with IRBESARTAN (Total Daily Dose: 300 Mg Unit Dose: 300 Mg) (View Irbesartan Review and Irbesartan Label ), AVLOCARDYL (Total Daily Dose: 40 Mg Unit Dose: 40 Mg) (View Avlocardyl Review and Avlocardyl Label ). Patient was hospitalized.

6636876-7 | Back Injury, Fall, Loss Of Consciousness, Malaise
Patient was taking Izilox (View Usage). After Izilox was administered, patient had the following side effects: back injury, fall (What is fall?), loss of consciousness, malaise on Mar 10, 2010 from FRANCE Additional patient health information: Female patient , 72 years of age, was diagnosed with lung disorder and. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. Patient was hospitalized.

6574119-3 | Depressed Level Of Consciousness, Erythema, Flushing, Hypertension
Adverse event was reported on Jan 30, 2010 by a Female patient taking Izilox (View Usage) (Dosage: ) was diagnosed with bronchitis (What is bronchitis?) and. Location: FRANCE , 47 years of age, Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, erythema, flushing, hypertension. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CELESTENE (View Celestene Review and Celestene Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ).

6553712-8 | Grand Mal Convulsion, Head Injury, Loss Of Consciousness
on Jan 20, 2010 Male patient from FRANCE , 43 years of age, was treated with Izilox (View Usage). Patient had the following side effects: grand mal convulsion, head injury, loss of consciousness. Izilox dosage: Unit Dose: 400 Mg. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), PROGRAF (Unit Dose: 0.5 Mg) (View Prograf Review and Prograf Label ). Patient was hospitalized.

6549749-5 | Rectal Haemorrhage
on Jan 19, 2010 Male patient from FRANCE , 87 years of age, was diagnosed with lung infection, hygroma colli, myocardial ischaemia and was treated with Izilox (View Usage). After Izilox was administered, patient had the following side effects: rectal haemorrhage. Izilox dosage: . During the same period patient was treated with NUREFLEX L.P. (Unit Dose: 300 Mg) (View Nureflex L.p. Review and Nureflex L.p. Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), PREVISCAN (View Previscan Review and Previscan Label ), CARDENSIEL (Long-term Treatment) (View Cardensiel Review and Cardensiel Label ), COVERSYL (Long-term Treatment) (View Coversyl Review and Coversyl Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), CORDARONE (View Cordarone Review and Cordarone Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

6535610-9 | Pruritus, Skin Test Negative, Type I Hypersensitivity, Urticaria
Patient was taking Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, skin test negative, type i hypersensitivity, urticaria on Dec 28, 2009 from FRANCE Additional patient health information: Female patient , 45 years of age, was diagnosed with bronchitis (What is bronchitis?), immunisation and. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with SOLUPRED 60 (View Solupred 60 Review and Solupred 60 Label ), SERETIDE DISKUS (As Used: 500/50 ?g) (View Seretide Diskus Review and Seretide Diskus Label ), VAXIGRIP (Total Daily Dose: 1 Df) (View Vaxigrip Review and Vaxigrip Label ), VENTOLIN (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

6531869-2 | Pruritus, Skin Test Negative, Type I Hypersensitivity, Urticaria
Adverse event was reported on Dec 28, 2009 by a Female patient taking Izilox (View Usage) (Dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg) was diagnosed with bronchitis (What is bronchitis?), immunisation and. Location: FRANCE , 45 years of age, Patient had the following side effects: pruritus, skin test negative, type i hypersensitivity, urticaria. During the same period patient was treated with SOLUPRED 60 (View Solupred 60 Review and Solupred 60 Label ), SERETIDE DISKUS (As Used: 500/50 ?g) (View Seretide Diskus Review and Seretide Diskus Label ), VAXIGRIP (Total Daily Dose: 1 Df) (View Vaxigrip Review and Vaxigrip Label ), VENTOLIN (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

6506526-9 | Pruritus, Pyrexia
on Dec 15, 2009 Male patient from FRANCE , 41 years of age, was diagnosed with arthropod bite, pulmonary tuberculosis and was treated with Izilox (View Usage). After Izilox was administered, patient had the following side effects: pruritus, pyrexia. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), SUBUTEX (Total Daily Dose: 16 Mg) (View Subutex Review and Subutex Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), RIFATER (View Rifater Review and Rifater Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ). Patient was hospitalized.

6506295-2 | Asthenia, Tremor, Vertigo, Vomiting
on Dec 15, 2009 Female patient from FRANCE , 37 years of age, was diagnosed with sinusitis (What is sinusitis?) and was treated with Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, tremor, vertigo, vomiting. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with RHINOFLUIMUCIL (View Rhinofluimucil Review and Rhinofluimucil Label ).

6404922-1 | Anaemia, Cerebral Haematoma, International Normalised Ratio Increased, Rectal Haemorrhage
Patient was taking Izilox (View Usage). Patient had the following side effects: anaemia, cerebral haematoma, international normalised ratio increased, rectal haemorrhage on Oct 09, 2009 from FRANCE Additional patient health information: Female patient , 97 years of age, . Izilox dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

6311385-3 | Cholestasis, Cytolytic Hepatitis, Hepatic Encephalopathy, Hepatitis Fulminant, Jaundice, Metabolic Acidosis, Tachypnoea
Adverse event was reported on Aug 06, 2009 by a Female patient taking Izilox (View Usage) (Dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg) was diagnosed with disseminated tuberculosis and. Location: FRANCE , 37 years of age, After Izilox was administered, patient had the following side effects: cholestasis, cytolytic hepatitis, hepatic encephalopathy, hepatitis fulminant, jaundice (What is jaundice?), metabolic acidosis, tachypnoea. During the same period patient was treated with RIFADIN (Total Daily Dose: 300 Mg Unit Dose: 300 Mg) (View Rifadin Review and Rifadin Label ), MYAMBUTOL (Total Daily Dose: 1200 Mg Unit Dose: 400 Mg) (View Myambutol Review and Myambutol Label ), RIMIFON (Total Daily Dose: 300 Mg Unit Dose: 150 Mg) (View Rimifon Review and Rimifon Label ), ANSATIPIN (Total Daily Dose: 150 Mg Unit Dose: 150 Mg) (View Ansatipin Review and Ansatipin Label ), PIRILENE (Total Daily Dose: 450 Mg Unit Dose: 150 Mg) (View Pirilene Review and Pirilene Label ), ZECLAR (View Zeclar Review and Zeclar Label ). Patient was hospitalized.

6289612-0 | Anaemia Haemolytic Autoimmune, Aplasia Pure Red Cell
on Jul 20, 2009 Female patient from FRANCE , 34 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia haemolytic autoimmune, aplasia pure red cell. Izilox dosage: . During the same period patient was treated with RIFATER (View Rifater Review and Rifater Label ). Patient was hospitalized.

6271307-0 | Confusional State, Fall, Hyperglycaemia, Renal Failure
on Jul 08, 2009 Female patient from FRANCE , 90 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Izilox (View Usage). Patient had the following side effects: confusional state, fall (What is fall?), hyperglycaemia, renal failure. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), AMLOR (View Amlor Review and Amlor Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), SOLUPRED (View Solupred Review and Solupred Label ), GALANTAMINE HYDROBROMIDE (View Galantamine Hydrobromide Review and Galantamine Hydrobromide Label ), SERESTA (View Seresta Review and Seresta Label ). Patient was hospitalized.

6263253-3 | Anaemia Haemolytic Autoimmune, Aplasia Pure Red Cell
Patient was taking Izilox (View Usage). After Izilox was administered, patient had the following side effects: anaemia haemolytic autoimmune, aplasia pure red cell on Jun 30, 2009 from FRANCE Additional patient health information: Female patient , 34 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and. Izilox dosage: . During the same period patient was treated with RIFATER (View Rifater Review and Rifater Label ). Patient was hospitalized.

6256585-6 | Anaemia Haemolytic Autoimmune, Aplasia Pure Red Cell
Adverse event was reported on Jun 30, 2009 by a Female patient taking Izilox (View Usage) (Dosage: ) was diagnosed with tuberculosis (What is tuberculosis?) and. Location: FRANCE , 34 years of age, Patient experienced the following unwanted or unexpected effects: anaemia haemolytic autoimmune, aplasia pure red cell. During the same period patient was treated with RIFATER (View Rifater Review and Rifater Label ). Patient was hospitalized.

6252637-5 | Neutropenia
on Jun 23, 2009 Male patient from FRANCE , 63 years of age, was diagnosed with type 2 diabetes mellitus, sinusitis (What is sinusitis?) and was treated with Izilox (View Usage). Patient had the following side effects: neutropenia. Izilox dosage: 1 Df Per Day. During the same period patient was treated with TOPREC (View Toprec Review and Toprec Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), QUININE VITAMINE C GRAND (View Quinine Vitamine C Grand Review and Quinine Vitamine C Grand Label ), AMAREL (View Amarel Review and Amarel Label ). Patient was hospitalized.

6252571-0 | Atrial Tachycardia
on Jun 19, 2009 Male patient from FRANCE , 80 years of age, was diagnosed with escherichia infection and was treated with Izilox (View Usage). After Izilox was administered, patient had the following side effects: atrial tachycardia. Izilox dosage: Total Daily Dose: 800 Mg Unit Dose: 400 Mg. During the same period patient was treated with HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), ATACAND (View Atacand Review and Atacand Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PLAVIX (View Plavix Review and Plavix Label ), LYRICA (View Lyrica Review and Lyrica Label ).

6251830-5 | Neutropenia
Patient was taking Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia on Jun 23, 2009 from FRANCE Additional patient health information: Male patient , 63 years of age, was diagnosed with type 2 diabetes mellitus, sinusitis (What is sinusitis?) and. Izilox dosage: 1 Df Per Day. During the same period patient was treated with TOPREC (View Toprec Review and Toprec Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), QUININE VITAMINE C GRAND (View Quinine Vitamine C Grand Review and Quinine Vitamine C Grand Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6160041-3 | Haematuria, International Normalised Ratio Increased, Prothrombin Time Ratio Decreased
Adverse event was reported on Apr 09, 2009 by a Female patient taking Izilox (View Usage) (Dosage: Unit Dose: 400 Mg) was diagnosed with bronchitis (What is bronchitis?) and. Location: FRANCE , 64 years of age, Patient had the following side effects: haematuria, international normalised ratio increased, prothrombin time ratio decreased. During the same period patient was treated with PREVISCAN (Unit Dose: 20 Mg) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6137727-X | Hepatic Encephalopathy
on Mar 17, 2009 Female patient from FRANCE , 56 years of age, was diagnosed with device related infection and was treated with Izilox (View Usage). After Izilox was administered, patient had the following side effects: hepatic encephalopathy. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with INVANZ (Unit Dose: 1 G) (View Invanz Review and Invanz Label ). Patient was hospitalized.

6134542-8 | Hepatic Encephalopathy
on Mar 17, 2009 Female patient from FRANCE , 56 years of age, was diagnosed with device related infection and was treated with Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic encephalopathy. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with INVANZ (Unit Dose: 1 G) (View Invanz Review and Invanz Label ). Patient was hospitalized.

6110871-9 | Chromatopsia, Glaucoma, Iris Hypopigmentation, Muscle Spasms, Uveitis, Vertigo
Patient was taking Izilox (View Usage). Patient had the following side effects: chromatopsia, glaucoma (What is glaucoma?), iris hypopigmentation, muscle spasms, uveitis, vertigo on Feb 25, 2009 from FRANCE Additional patient health information: Male patient , 28 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with DEXAMBUTOL (Total Daily Dose: 1000 Mg Unit Dose: 1000 Mg) (View Dexambutol Review and Dexambutol Label ), PIRILENE (View Pirilene Review and Pirilene Label ), ETHIONAMIDE (View Ethionamide Review and Ethionamide Label ), CAPREOMYCIN (View Capreomycin Review and Capreomycin Label ).

6107292-1 | Chromatopsia, Glaucoma, Iris Hypopigmentation, Muscle Spasms, Uveitis, Vertigo
Adverse event was reported on Feb 25, 2009 by a Male patient taking Izilox (View Usage) (Dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg) was diagnosed with tuberculosis (What is tuberculosis?) and. Location: FRANCE , 28 years of age, After Izilox was administered, patient had the following side effects: chromatopsia, glaucoma (What is glaucoma?), iris hypopigmentation, muscle spasms, uveitis, vertigo. During the same period patient was treated with DEXAMBUTOL (Total Daily Dose: 1000 Mg Unit Dose: 1000 Mg) (View Dexambutol Review and Dexambutol Label ), PIRILENE (View Pirilene Review and Pirilene Label ), ETHIONAMIDE (View Ethionamide Review and Ethionamide Label ), CAPREOMYCIN (View Capreomycin Review and Capreomycin Label ).

6083372-4 | Abasia, Anaphylactic Reaction, Asthma, Blood Pressure Decreased, Dyspnoea, Fatigue, Hypotension, Monoplegia, Pain
on Feb 17, 2009 Female patient from FRANCE , 63 years of age, was diagnosed with bronchitis bacterial, eosinophilic pneumonia and was treated with Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, anaphylactic reaction, asthma (What is asthma?), blood pressure decreased, dyspnoea, fatigue, hypotension, monoplegia, pain (What is pain?). Izilox dosage: Total Daily Dose: 400 Mg. During the same period patient was treated with CORTICOIDS (View Corticoids Review and Corticoids Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), BECOTIDE (View Becotide Review and Becotide Label ), NASONEX (View Nasonex Review and Nasonex Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6083365-7 | Aphthous Stomatitis, Fatigue, Glossitis, Mouth Ulceration, Oedema Peripheral, Pain, Spontaneous Haematoma
on Feb 16, 2009 Male patient from FRANCE , 64 years of age, weighting 167.6 lb, was diagnosed with infection (What is infection?) and was treated with Izilox (View Usage). Patient had the following side effects: aphthous stomatitis, fatigue, glossitis, mouth ulceration, oedema peripheral, pain (What is pain?), spontaneous haematoma. Izilox dosage: .

6073490-9 | Aphthous Stomatitis, Fatigue, Glossitis, Haematoma, Mouth Ulceration, Oedema Peripheral, Pain
Patient was taking Izilox (View Usage). After Izilox was administered, patient had the following side effects: aphthous stomatitis, fatigue, glossitis, haematoma, mouth ulceration, oedema peripheral, pain (What is pain?) on Feb 06, 2009 from FRANCE Additional patient health information: Male patient , 64 years of age, was diagnosed with infection (What is infection?) and. Izilox dosage: .

6062227-5 | Headache, Hemiparesis, International Normalised Ratio Increased, Paraesthesia, Subdural Haematoma
Adverse event was reported on Jan 28, 2009 by a Female patient taking Izilox (View Usage) (Dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg) was diagnosed with portal vein thrombosis, acute sinusitis and. Location: FRANCE , 29 years of age, Patient experienced the following unwanted or unexpected effects: headache (What is headache?), hemiparesis, international normalised ratio increased, paraesthesia, subdural haematoma. During the same period patient was treated with SOLUPRED (Total Daily Dose: 50 Mg Unit Dose: 50 Mg) (View Solupred Review and Solupred Label ), PREVISCAN (View Previscan Review and Previscan Label ), CELLCEPT (Unit Dose: 500 Mg) (View Cellcept Review and Cellcept Label ), KENZEN (Unit Dose: 4 Mg) (View Kenzen Review and Kenzen Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), ZECLAR (View Zeclar Review and Zeclar Label ). Patient was hospitalized.

6060913-4 | Headache, Hemiparesis, International Normalised Ratio Increased, Paraesthesia, Subdural Haematoma
on Jan 28, 2009 Female patient from FRANCE , 29 years of age, was diagnosed with portal vein thrombosis, acute sinusitis and was treated with Izilox (View Usage). Patient had the following side effects: headache (What is headache?), hemiparesis, international normalised ratio increased, paraesthesia, subdural haematoma. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with SOLUPRED (Total Daily Dose: 50 Mg Unit Dose: 50 Mg) (View Solupred Review and Solupred Label ), PREVISCAN (View Previscan Review and Previscan Label ), CELLCEPT (Unit Dose: 500 Mg) (View Cellcept Review and Cellcept Label ), KENZEN (Unit Dose: 4 Mg) (View Kenzen Review and Kenzen Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), ZECLAR (View Zeclar Review and Zeclar Label ). Patient was hospitalized.

6056451-5 | Anaphylactic Reaction, Asthma, Condition Aggravated, Dyspnoea, Fatigue, Hypotension, Pain In Extremity, Paralysis, Respiratory Tract Congestion
on Jan 21, 2009 Female patient from FRANCE , 63 years of age, was diagnosed with bronchitis bacterial, eosinophilic pneumonia and was treated with Izilox (View Usage). After Izilox was administered, patient had the following side effects: anaphylactic reaction, asthma (What is asthma?), condition aggravated, dyspnoea, fatigue, hypotension, pain in extremity, paralysis (What is paralysis?), respiratory tract congestion. Izilox dosage: . During the same period patient was treated with CORTICOIDS (View Corticoids Review and Corticoids Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), BECOTIDE (View Becotide Review and Becotide Label ), NASONEX (View Nasonex Review and Nasonex Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6020095-1 | Cytolytic Hepatitis
Patient was taking Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis on Dec 16, 2008 from FRANCE Additional patient health information: Male patient , 63 years of age, was diagnosed with prostatitis, arthritis (What is arthritis?) and. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with BIPROFENID (Total Daily Dose: 300 Mg) (View Biprofenid Review and Biprofenid Label ), PARACETAMOL (Total Daily Dose: 3 G) (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

5986093-9 | Head Injury, Loss Of Consciousness, Malaise
Adverse event was reported on Nov 27, 2008 by a Female patient taking Izilox (View Usage) (Dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg) was diagnosed with sinus headache, colitis ischaemic and. Location: FRANCE , 48 years of age, Patient had the following side effects: head injury, loss of consciousness, malaise. During the same period patient was treated with IXPRIM (View Ixprim Review and Ixprim Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ). Patient was hospitalized.

5941424-0 | Atrioventricular Block First Degree, Hypokalaemia, Loss Of Consciousness, Malaise, Palpitations
on Oct 30, 2008 Female patient from FRANCE , 38 years of age, was treated with Izilox (View Usage). After Izilox was administered, patient had the following side effects: atrioventricular block first degree, hypokalaemia, loss of consciousness, malaise, palpitations. Izilox dosage: . Patient was hospitalized.

5886121-5 | Depression, Head Banging, Hepatitis, Nervous System Disorder, Paraesthesia, Tendon Pain, Tinnitus, Transaminases Increased, Weight Decreased
on Sep 10, 2008 Male patient from FRANCE , 52 years of age, weighting 187.4 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), head banging, hepatitis (What is hepatitis?), nervous system disorder, paraesthesia, tendon pain, tinnitus (What is tinnitus?), transaminases increased, weight decreased. Izilox dosage: . During the same period patient was treated with OFLOCET (View Oflocet Review and Oflocet Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DESMODIUM (DESMODIUM ASCENDENS) (View Desmodium (desmodium Ascendens) Review and Desmodium (desmodium Ascendens) Label ). Patient was hospitalized.

5868629-1 | Depression, Head Banging, Hepatitis, Nervous System Disorder, Paraesthesia, Tendon Pain, Tinnitus, Transaminases Increased, Weight Decreased
Patient was taking Izilox (View Usage). Patient had the following side effects: depression (What is depression?), head banging, hepatitis (What is hepatitis?), nervous system disorder, paraesthesia, tendon pain, tinnitus (What is tinnitus?), transaminases increased, weight decreased on Aug 26, 2008 from FRANCE Additional patient health information: Male patient , 52 years of age, weighting 187.4 lb, was diagnosed with sinusitis (What is sinusitis?) and. Izilox dosage: . During the same period patient was treated with OFLOCET (View Oflocet Review and Oflocet Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DESMODIUM (DESMODIUM ASCENDENS) (View Desmodium (desmodium Ascendens) Review and Desmodium (desmodium Ascendens) Label ). Patient was hospitalized.

5866755-4 | Anaphylactic Shock, Bradycardia, Circulatory Collapse, Hypotension, Syncope, Urinary Incontinence, Urticaria
Adverse event was reported on Aug 26, 2008 by a Female patient taking Izilox (View Usage) (Dosage: ) was diagnosed with acute sinusitis and. Location: FRANCE , 52 years of age, weighting 116.8 lb, After Izilox was administered, patient had the following side effects: anaphylactic shock, bradycardia, circulatory collapse, hypotension, syncope, urinary incontinence (What is urinary incontinence?), urticaria. During the same period patient was treated with CEPHALOSPORINS (View Cephalosporins Review and Cephalosporins Label ), MACROLIDES (View Macrolides Review and Macrolides Label ). Patient was hospitalized.

5862510-X | Aphasia, Dyspnoea, Oropharyngeal Discomfort, Rash, Transient Ischaemic Attack, Vertigo
on Aug 18, 2008 Female patient from FRANCE , 73 years of age, was treated with Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), dyspnoea, oropharyngeal discomfort, rash (What is rash?), transient ischaemic attack, vertigo. Izilox dosage: . During the same period patient was treated with AMLOR (Total Daily Dose: 10 Mg Unit Dose: 5 Mg) (View Amlor Review and Amlor Label ), TAREG (Total Daily Dose: 40 Mg Unit Dose: 40 Mg) (View Tareg Review and Tareg Label ), REFRESH NOS (View Refresh Nos Review and Refresh Nos Label ), VITABACT (View Vitabact Review and Vitabact Label ). Patient was hospitalized.

5859799-X | Pancytopenia
on Aug 18, 2008 Male patient from FRANCE , 52 years of age, was treated with Izilox (View Usage). Patient had the following side effects: pancytopenia. Izilox dosage: . Patient was hospitalized.

5835253-6 | Arthralgia, Synovitis
Patient was taking Izilox (View Usage). After Izilox was administered, patient had the following side effects: arthralgia, synovitis on Jul 30, 2008 from FRANCE Additional patient health information: Male patient , 41 years of age, weighting 160.9 lb, was diagnosed with tuberculosis (What is tuberculosis?), leukaemia, hiv infection (What is hiv infection?) and. Izilox dosage: . During the same period patient was treated with ANSATIPIN (Total Daily Dose: 225 Mg Unit Dose: 225 Mg) (View Ansatipin Review and Ansatipin Label ), KALETRA (View Kaletra Review and Kaletra Label ), VIREAD (View Viread Review and Viread Label ), INTERFERON ALFA (View Interferon Alfa Review and Interferon Alfa Label ), COMBIVIR (View Combivir Review and Combivir Label ), ETHAMBUTOL HCL (View Ethambutol Hcl Review and Ethambutol Hcl Label ).

5819520-8 | Dysaesthesia, Dysuria, Pain In Extremity, Polyneuropathy
Adverse event was reported on Jul 17, 2008 by a Male patient taking Izilox (View Usage) (Dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg) . Location: FRANCE , 30 years of age, weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: dysaesthesia, dysuria, pain in extremity, polyneuropathy. During the same period patient was treated with ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), CYCLOSERINE (Unit Dose: 750 Mg) (View Cycloserine Review and Cycloserine Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), P.A.S. (View P.a.s. Review and P.a.s. Label ). Patient was hospitalized and became disabled.

5816915-3 | Cytolytic Hepatitis, Hyperthermia, Rash Maculo-papular
on Jul 03, 2008 Female patient from FRANCE , 43 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Izilox (View Usage). Patient had the following side effects: cytolytic hepatitis, hyperthermia, rash maculo-papular. Izilox dosage: . During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), PIRILENE (View Pirilene Review and Pirilene Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), ANSATIPIN (View Ansatipin Review and Ansatipin Label ). Patient was hospitalized.

5811983-7 | Cytolytic Hepatitis, Hyperthermia, Rash Maculo-papular
on Jul 03, 2008 Female patient from FRANCE , 43 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Izilox (View Usage). After Izilox was administered, patient had the following side effects: cytolytic hepatitis, hyperthermia, rash maculo-papular. Izilox dosage: . During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), PIRILENE (View Pirilene Review and Pirilene Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), ANSATIPIN (View Ansatipin Review and Ansatipin Label ). Patient was hospitalized.

5807114-X | Dysaesthesia, Dysuria, Pain In Extremity, Polyneuropathy
Patient was taking Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: dysaesthesia, dysuria, pain in extremity, polyneuropathy on Jul 02, 2008 from FRANCE Additional patient health information: Male patient , 30 years of age, weighting 114.6 lb, . Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), CYCLOSERINE (Unit Dose: 750 Mg) (View Cycloserine Review and Cycloserine Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), P.A.S. (View P.a.s. Review and P.a.s. Label ). Patient was hospitalized and became disabled.

5797006-7 | Anaemia, Fall, Haematoma
Adverse event was reported on Jun 25, 2008 by a Female patient taking Izilox (View Usage) (Dosage: ) . Location: FRANCE , 86 years of age, Patient had the following side effects: anaemia, fall (What is fall?), haematoma. During the same period patient was treated with PRAVADUAL (PRAVASTATIN /W ACETYLSALICYLIC ACID) (View Pravadual (pravastatin /w Acetylsalicylic Acid) Review and Pravadual (pravastatin /w Acetylsalicylic Acid) Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DETENSIEL (View Detensiel Review and Detensiel Label ), CERIS (View Ceris Review and Ceris Label ), ECONAZOLE NITRATE (View Econazole Nitrate Review and Econazole Nitrate Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

5797004-3 | Depersonalisation, Hallucination, Hearing Impaired, Malaise, Panic Reaction, Vertigo, Visual Impairment
on Jun 26, 2008 Male patient from FRANCE , 51 years of age, was treated with Izilox (View Usage). After Izilox was administered, patient had the following side effects: depersonalisation, hallucination, hearing impaired, malaise, panic reaction, vertigo, visual impairment. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with DERINOX (NAPHAZOLINE) (View Derinox (naphazoline) Review and Derinox (naphazoline) Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DIOALGO (View Dioalgo Review and Dioalgo Label ), CIBLOR (View Ciblor Review and Ciblor Label ).

5755194-2 | Abdominal Pain Upper, Cytolytic Hepatitis, Nausea, Ocular Icterus
on May 26, 2008 Female patient from FRANCE , 35 years of age, was diagnosed with disseminated tuberculosis and was treated with Izilox (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, cytolytic hepatitis, nausea (What is nausea?), ocular icterus. Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), CYCLADOL (View Cycladol Review and Cycladol Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), PIRILENE (View Pirilene Review and Pirilene Label ). Patient was hospitalized.

5749806-7 | Cytolytic Hepatitis
Patient was taking Izilox (View Usage). Patient had the following side effects: cytolytic hepatitis on May 21, 2008 from FRANCE Additional patient health information: Female patient , 35 years of age, . Izilox dosage: Total Daily Dose: 400 Mg Unit Dose: 400 Mg. During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), CYCLADOL (View Cycladol Review and Cycladol Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PIRILENE (View Pirilene Review and Pirilene Label ), AMIKACIN (View Amikacin Review and Amikacin Label ). Patient was hospitalized.